IndraLab

Statements



reach
"They further showed that some DUBs that have been exposed to ROS can have different responses to reduction through DTT treatment, with some being activated by DTT (e.g., USP8, USP10, and USP19), some having only enhancement of activity in the presence of DTT (e.g., USP7, CYLD, and UCHL5), and others exhibiting no activity, despite the presence of a reducing agent (e.g., USP1, USP22, and A20) (35)."

reach
"Purified USP19CD behaved similarly to full-length USP19 as it contained little activity unless treated with DTT (XREF_SUPPLEMENTARY)."